These ten large-cap stocks were the worst performers last week. Are they aΒ part of your portfolio?
01. Nutanix, Inc. (NASDAQ: NTNX) fell 18.06% this week after the company reported worse-than-expected first-quarter sales results and issued second-quarter sales guidance below estimates. Additionally, the company has lowered its 2026 sales guidance below expectations. Multiple analysts cut their price forecasts on the stock.
02. Veeva Systems Inc. (NYSE: VEEV) decreased 3.79% this week. Citigroup analyst Tyler Radke maintains a Buy rating for Veeva Systems and lowers the price forecast from $349 to $319.
03. Burlington Stores, Inc. (NYSE: BURL) fell 11.09% this week after the company reported mixed third-quarter financial results. The company announced that its traffic to stores fell significantly after the back-to-school period.
04. Zscaler, Inc. (NASDAQ: ZS) decreased 9.53% this week after the company reported first-quarter financial results. Mizuho analyst Gregg Moskowitz maintained a Neutral rating, lowering the price forecast from $325 to $310.
05. Warner Music Group Corp. (NASDAQ: WMG) slumped 5.14% this week.
06. Oracle Corporation (NYSE: ORCL) decreased 2.58% this week. DA Davidson analyst Gil Luria maintains a Neutral rating, lowering the price forecast from $300 to $200.
07. Ecopetrol S.A. (NYSE: EC) fell 2.31% this week.
08. AECOM (NYSE: ACM) decreased 1.77% this week. Last week, Baird analyst Andrew Wittmann downgraded the stock from Outperform to Neutral and maintained the price forecast at $143.
09. Deere & Company (NYSE: DE) decreased 2.75% this week. The company said it expects a pre-tax annual tariff hit of about $1.2 billion. Evercore ISI Group analyst David Raso lowered the price forecast from $487 to $458.
10. BeOne Medicines Ltd. (NASDAQ: ONC) decreased 1.28% this week. The firm said it receives U.S. FDA priority review for Sonrotoclax in relapsed or refractory mantle cell lymphoma after BTK Inhibitor therapy.
These ten large-cap stocks were the worst performers last week. Are they aΒ part of your portfolio?
01. **Nutanix, Inc**. (NASDAQ: NTNX) fell 18.06% this week after the company reported worse-than-expected first-quarter sales results and issued second-quarter sales guidance below estimates. Additionally, the company has lowered its 2026 sales guidance below expectations. Multiple analysts cut their price forecasts on the stock.
02. **Veeva Systems Inc.** (NYSE: VEEV) decreased 3.79% this week. Citigroup analyst Tyler Radke maintains a Buy rating for Veeva Systems and lowers the price forecast from $349 to $319.
03. **Burlington Stores, Inc.** (NYSE: BURL) fell 11.09% this week after the company reported mixed third-quarter financial results. The company announced that its traffic to stores fell significantly after the back-to-school period.
04. **Zscaler, Inc.** (NASDAQ: ZS) decreased 9.53% this week after the company reported first-quarter financial results. **Mizuho** analyst Gregg Moskowitz maintained a Neutral rating, lowering the price forecast from $325 to $310.
05. **Warner Music Group Corp.** (NASDAQ: WMG) slumped 5.14% this week.
06. **Oracle Corporation** (NYSE: ORCL) decreased 2.58% this week. **DA Davidson** analyst Gil Luria maintains a Neutral rating, lowering the price forecast from $300 to $200.
07. **Ecopetrol S.A**. (NYSE: EC) fell 2.31% this week.
08. **AECOM** (NYSE: ACM) decreased 1.77% this week. Last week, Baird analyst Andrew Wittmann downgraded the stock from Outperform to Neutral and maintained the price forecast at $143.
09. **Deere & Company** (NYSE: DE) decreased 2.75% this week. The company said it expects a pre-tax annual tariff hit of about $1.2 billion. Evercore ISI Group analyst David Raso lowered the price forecast from $487 to $458.
10. **BeOne Medicines Ltd.** (NASDAQ: ONC) decreased 1.28% this week. The firm said it receives U.S. FDA priority review for Sonrotoclax in relapsed or refractory mantle cell lymphoma after BTK Inhibitor therapy.
<p>These ten large-cap stocks were the worst performers last week. Are they a <a target="_blank" href="https://www.benzinga.com/trading-ideas" rel="noreferrer noopener">part of your portfolio</a>?</p>
<ol class="wp-block-list">
<li><strong>Nutanix, Inc</strong>. <a href="https://www.benzinga.com/quote/NTNX" target="_blank" class="ticker-link" data-ticker="NTNX" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/NTNX">NTNX</a>)</a> fell 18.06% this week after the company reported worse-than-expected first-quarter sales results and issued second-quarter sales guidance below estimates. Additionally, the company has lowered its 2026 sales guidance below expectations. Multiple analysts cut<a href="https://www.benzinga.com/Opinion/25/11/49116358/why-nutanix-18-percent-decline-should-not-surprise-investors" target="_blank" rel="noreferrer noopener"> their price forecasts on the stock.</a></li>
<li><strong>Veeva Systems Inc.</strong> <a href="https://www.benzinga.com/quote/VEEV" target="_blank" class="ticker-link" data-ticker="VEEV" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/VEEV">VEEV</a>)</a> decreased 3.79% this week. Citigroup analyst Tyler Radke maintains a Buy rating for Veeva Systems and lowers <a href="https://www.benzinga.com/quote/VEEV/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast from $349 to $319.</a></li>
<li><strong>Burlington Stores, Inc.</strong> <a href="https://www.benzinga.com/quote/BURL" target="_blank" class="ticker-link" data-ticker="BURL" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/BURL">BURL</a>)</a> fell 11.09% this week after the company reported mixed third-quarter financial results. The company announced that its traffic to stores fell <a href="https://www.benzinga.com/markets/earnings/25/11/49058363/unseasonably-warm-weather-hits-burlington-revenue" target="_blank" rel="noreferrer noopener">significantly after the back-to-school period.</a></li>
<li><strong>Zscaler, Inc.</strong> <a href="https://www.benzinga.com/quote/ZS" target="_blank" class="ticker-link" data-ticker="ZS" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ZS">ZS</a>)</a> decreased 9.53% this week after the company reported first-quarter financial results. <strong>Mizuho </strong>analyst Gregg Moskowitz maintained a Neutral rating, <a href="https://www.benzinga.com/quote/ZS/analyst-ratings" target="_blank" rel="noreferrer noopener">lowering the price forecast from $325 to $310.</a></li>
<li><strong>Warner Music Group Corp.</strong> <a href="https://www.benzinga.com/quote/WMG" target="_blank" class="ticker-link" data-ticker="WMG" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/WMG">WMG</a>)</a> slumped 5.14% this week.</li>
<li><strong>Oracle Corporation</strong> <a href="https://www.benzinga.com/quote/ORCL" target="_blank" class="ticker-link" data-ticker="ORCL" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ORCL">ORCL</a>)</a> decreased 2.58% this week. <strong>DA Davidson</strong> analyst Gil Luria maintains a Neutral rating, lowering <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast from $300 to $200.</a></li>
<li><strong>Ecopetrol S.A</strong>. <a href="https://www.benzinga.com/quote/EC" target="_blank" class="ticker-link" data-ticker="EC" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/EC">EC</a>)</a> fell 2.31% this week.</li>
<li><strong>AECOM </strong><a href="https://www.benzinga.com/quote/ACM" target="_blank" class="ticker-link" data-ticker="ACM" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ACM">ACM</a>)</a> decreased 1.77% this week. Last week, Baird analyst Andrew Wittmann downgraded the stock from Outperform to Neutral and <a href="https://www.benzinga.com/quote/ACM/analyst-ratings" target="_blank" rel="noreferrer noopener">maintained the price forecast at $143.</a></li>
<li><strong>Deere & Company</strong> <a href="https://www.benzinga.com/quote/DE" target="_blank" class="ticker-link" data-ticker="DE" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/DE">DE</a>)</a> decreased 2.75% this week. The company said it expects a pre-tax annual tariff hit of about $1.2 billion. Evercore ISI Group analyst David Raso <a href="https://www.benzinga.com/markets/earnings/25/11/49083060/deere-says-large-ag-hits-bottom-in-2026-with-tariffs-still-hurting" target="_blank" rel="noreferrer noopener">lowered the price forecast from $487 to $458.</a></li>
<li><strong>BeOne Medicines Ltd.</strong> <a href="https://www.benzinga.com/quote/ONC" target="_blank" class="ticker-link" data-ticker="ONC" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ONC">ONC</a>)</a> decreased 1.28% this week. The firm said it receives U.S. FDA priority review for Sonrotoclax in relapsed or refractory mantle cell lymphoma after BTK Inhibitor therapy.</li>
</ol>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><em><a href="https://www.benzinga.com/news/politics/25/11/49125550/trump-may-formally-offer-putin-control-of-occupied-ukrainian-land-in-proposed-peace-deal" target="_blank" rel="noreferrer noopener">Trump May Formally Offer Putin Control of Occupied Ukrainian Land in Proposed Peace Deal</a></em></strong></li>
</ul>